About
Eko Health is a digital health company focused on improving the detection and monitoring of heart and lung diseases through innovative medical technology. The company develops digital stethoscopes, patient and provider software, and AI-powered analysis tools that enhance clinical accuracy in cardiovascular and pulmonary care. With its FDA-cleared platform, Eko's technology is used by over 500,000 healthcare professionals globally to facilitate early disease detection and improve patient outcomes. Founded by Connor Landgraf and his classmates at UC Berkeley, Eko Health has created multiple generations of digital stethoscopes, including the Eko CORE™ Digital Stethoscope and the DUO ECG + Digital Stethoscope. These devices feature enhanced audio clarity, active noise cancellation, and integrated ECG capabilities. Eko's products also include AI algorithms for detecting heart murmurs and atrial fibrillation, as well as cloud-based patient record storage for effective health tracking and collaboration among healthcare providers. Headquartered in Emeryville, California, Eko Health has raised over $165 million in funding and is recognized for its contributions to modernizing cardiovascular care.
Technologies
Keywords
Company Information
-
Employees 200
-
Founded 2013
-
Annual Revenue $20000000
-
Total Funding $173200000
Location
2100 Powell St, Emeryville, California, United States, 94608-1826
